-
NVP-BGJ398 Phosphate: FGFR3 Assay Logic
2026-09-20
NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor with applications spanning genotype-selected cancer models and FGFR3-driven skeletal disease research. This article explains how the pivotal mouse study supports a causal, orthogonal assay strategy rather than a simple viability-based readout.
-
Machine Learning Prediction of mRNA Vaccine LNPs
2026-09-19
The 2022 study developed a LightGBM model from 325 mRNA vaccine lipid nanoparticle formulations and achieved an R² above 0.87 for formulation-performance prediction. By combining computational interpretation, mouse validation, and molecular dynamics, it showed how machine learning can prioritize ionizable lipids and formulation conditions while reducing reliance on exhaustive experimental screening.
-
CNQX Workflows for AMPA/Kainate Circuit Mapping
2026-09-19
CNQX provides a practical way to separate AMPA/kainate-driven excitation from NMDA-dependent signaling in cellular, slice, and systems neuroscience. This guide translates its receptor pharmacology into reproducible workflows, with special attention to the cNTS–PVN cardiovascular study and the controls needed to interpret a negative CNQX result.
-
Hexetidine (NSC-17764): From MIC to Mouthwash
2026-09-18
Hexetidine (NSC-17764) bridges membrane-active antimicrobial research and oral-care applications, but its value depends on assay context. This evidence-led guide connects MIC data, biofilm inhibition assay design, formulation limits, and clinical findings without equating laboratory potency with clinical superiority.
-
CSBTA Pharmacokinetics in MASH Mice
2026-09-18
The 2025 Biomedicine & Pharmacotherapy study integrates disease-state pharmacokinetics, tissue distribution, transporter assays, and metabolic-enzyme analysis to explain how Corydalis saxicola Bunting total alkaloids behave in MASH-model mice. Its findings indicate that HFHCD-associated pathology and repeated dosing increase systemic exposure and hepatic accumulation of key alkaloids, with implications for dose-regimen design and pharmacokinetic variability.
-
Calpeptin Workflow for Pulmonary Fibrosis Research
2026-09-17
Calpeptin provides a practical way to interrogate calcium-dependent protease signaling alongside inflammatory, fibrotic, and cell-death readouts. This workflow emphasizes dose-finding, orthogonal validation, and troubleshooting so biochemical potency is not mistaken for a universal cellular dose.
-
NAD+ Assay Workflows: SKU B1793
2026-09-17
This scenario-based guide explains how Nicotinamide Adenine Dinucleotide (NAD+) can be incorporated into viability, proliferation, cytotoxicity, and energy-stress experiments without confusing redox effects with cell number. It provides practical handling guidance for SKU B1793, including solvent compatibility, storage, controls, and interpretation limits.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-09-16
This study identifies striatal D2 receptor-expressing medium spiny neurons as a cell population linking Neuroligin 1 loss to excessive self-grooming and digging in mice. By combining behavior, activity manipulation, single-nucleus RNA sequencing, and protein validation, it implicates abnormal PKC signaling and distinct D2-MSN activity patterns in repetitive behavior.
-
PLGA Microspheres for Controlled Corticosteroid Delivery
2026-09-15
A 2026 Pharmaceutics study shows that PLGA microsphere size, surface chemistry, and corticosteroid stability jointly determine performance in cartilage delivery. Its findings distinguish apparent diffusion-model fit from the steric constraints of the collagen network and identify PEGylation as a strategy for preserving hydrocortisone-17-butyrate during release.
-
ZK53: A Metabolic Stress Map for ClpP Research
2026-09-15
ZK53 is a selective human mitochondrial serine protease ClpP activator that converts mitochondrial proteostasis failure into measurable cancer-cell stress. This guide connects ClpP activation with translatome-aware assay design, oxidative phosphorylation disruption, DNA-damage signaling, and ferroptosis sensitivity.
-
PD 0332991 in Gastric Cancer Assembloid Assays
2026-09-14
Use PD 0332991 (Palbociclib HCl) to connect CDK4/6 biology with patient-derived gastric cancer organoid and assembloid testing. This workflow separates tumor-cell sensitivity from stromal protection, enabling more informative G1-arrest, Rb signaling, and viability measurements.
-
mRNA Vaccine Memory: Antigen Versus LNP Immunity
2026-09-14
The reference study presents SAPC-LNPs, a sialic acid– and cleavable-PEG-modified delivery system designed to strengthen antigen-specific immune memory while limiting immune memory against the nanoparticle carrier. In a mouse cancer-vaccine setting, this balance was associated with improved endosomal escape, fewer formulation-related effects, and more durable antitumor protection after repeated administration.
-
Oridonin, Inflammation, and Esophageal Cancer
2026-09-13
Peng et al. investigated whether oridonin can counter esophageal cancer-associated inflammation through the TLR4/NF-κB/NLRP3 inflammasome axis in a 4-nitroquinoline N-oxide mouse model. The integrated pathology, hematology, cytokine, qPCR, and western blot findings support pathway-linked anti-inflammatory activity, while the preclinical design does not yet establish direct molecular causality or clinical efficacy.
-
Bismuth Subsalicylate in GI Assay Design
2026-09-12
Bismuth Subsalicylate can do more than support gastrointestinal disorder research when its chemical behavior, prostaglandin pathway activity, and membrane-based apoptosis readouts are interpreted together. This article presents an orthogonal assay strategy grounded in product specifications and annexin V methodology.
-
iRhom2, Olfactory Receptors, and Sensory Adaptation
2026-09-12
Azzopardi and colleagues identify iRhom2 as a previously underappreciated regulator in olfactory sensory neurons, linking odorant receptor expression with activity-dependent adaptation. Their combination of knockout analysis, transcriptomics, spatial validation, and receptor signaling experiments supports an iRhom2/ADAM17 feedback model while also defining important limits for mechanistic interpretation.